OFFICE LEASE BY AND BETWEEN a California limited partnership AS LANDLORD AND ElDOS THERAPEUTICS, INC., a Delaware corporation, AS TENANT PREMISES: San Francisco, CaliforniaOffice Lease • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • California
THIS OFFICE LEASE (this “Lease”) is made as of the 14th day of November, 2017, by and between 101 Montgomery Street Co., a California limited partnership (“Landlord”), and Eidos Therapeutics, Inc., a Delaware corporation (“Tenant”).
INTERCOMPANY SERVICES AGREEMENTIntercompany Services Agreement • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • California
This INTERCOMPANY SERVICES AGREEMENT (this “Agreement”), dated May 1, 2017 and effective as of May 1, 2017 (the “Effective Date”), is made and entered into by and between BridgeBio Services Inc., a Delaware corporation (the “Provider”), and Eidos Therapeutics, Inc., a Delaware corporation (the “Recipient”). The Provider and the Recipient may be referred to collectively herein as the “Parties” and each, a “Party.”
EIDOS THERAPEUTICS, INC. INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of April, 2016, by and among Eidos Therapeutics, Inc. a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 5.9 hereof.
QB3@953 Sublease Agreement (the “Agreement”)953 Sublease Agreement • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations
QB3 Incubator Partners, LP (“Landlord”) and Eidos Therapeutics, Inc., a State of Delaware C-Corporation (“Tenant”) agree as follows:
ContractPurchase Agreement • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.
